Latest Articles
Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies - Il Sole 24 ORE
Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies Il Sole 24 ORE
Published: Feb. 5, 2026, 10:31 a.m.
How Immunotherapy Helps Women With Advanced Endometrial Cancer - Banner Health
How Immunotherapy Helps Women With Advanced Endometrial Cancer Banner Health
Published: Jan. 28, 2026, 7:05 p.m.
Immunotherapy and Targeted Strategies Reshape Endometrial Cancer Care at New Jersey Prominent Trial Site - trialsitenews.com
Immunotherapy and Targeted Strategies Reshape Endometrial Cancer Care at New Jersey Prominent Trial Site trialsitenews.com
Published: Jan. 25, 2026, 7:10 a.m.
Immunotherapy for Advanced Endometrial Cancer - Banner Health
Immunotherapy for Advanced Endometrial Cancer Banner Health
Published: Jan. 8, 2026, 12:51 p.m.
Immunotherapy in Endometrial Cancer: Mechanisms, Clinical Evidence, and Future Directions - Frontiers
Immunotherapy in Endometrial Cancer: Mechanisms, Clinical Evidence, and Future Directions Frontiers
Published: Dec. 17, 2025, 5:24 p.m.
Frontline Considerations for Immunotherapy in Endometrial Cancer - OncLive
Frontline Considerations for Immunotherapy in Endometrial Cancer OncLive
Published: Nov. 3, 2025, 1:36 p.m.
WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer - OncLive
WES-Aneuploidy Scores May Be Prognostic for Immunotherapy in dMMR Endometrial Cancer OncLive
Published: Oct. 23, 2025, 6:03 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - Bioengineer.org
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival Bioengineer.org
Published: Oct. 14, 2025, 4:49 p.m.
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival - BIOENGINEER.ORG
Immunotherapy Plus Chemotherapy Boosts Endometrial Cancer Survival BIOENGINEER.ORG
Published: Oct. 14, 2025, 4:49 p.m.
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials - BMC Cancer
Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials BMC Cancer
Published: Oct. 14, 2025, 2:41 p.m.
Link copied to clipboard!